427 related articles for article (PubMed ID: 18984307)
1. [Molecular markers having a prognostic or therapeutic value in cancer].
Brousset P
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
[No Abstract] [Full Text] [Related]
2. [Gene expression profiles in the diagnosis and prognosis of cancer].
Kopper L; Tímár J
Magy Onkol; 2002; 46(1):3-9. PubMed ID: 12050676
[TBL] [Abstract][Full Text] [Related]
3. DualChip microarray as a new tool in cancer research.
Gillet JP; de Longueville F; Remacle J
Expert Rev Mol Diagn; 2006 May; 6(3):295-306. PubMed ID: 16706734
[TBL] [Abstract][Full Text] [Related]
4. [The pathologist and targeted therapies in oncology].
Bertheau P
Ann Pathol; 2009 Nov; 29 Spec No 1():S69-70. PubMed ID: 19887258
[No Abstract] [Full Text] [Related]
5. Prognostic factors in multiple myeloma.
Tricot G
Clin Adv Hematol Oncol; 2005 Mar; 3(3):167-8. PubMed ID: 16166987
[No Abstract] [Full Text] [Related]
6. The footprints of cancer development: Cancer biomarkers.
Ullah MF; Aatif M
Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
[TBL] [Abstract][Full Text] [Related]
7. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
Mitra AP; Lin H; Cote RJ; Datar RH
Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
[TBL] [Abstract][Full Text] [Related]
8. [Molecular genetic tumor markers and their analysis for diagnosis and therapy of cancer patients].
Ianov IuK; Novik AA; Belokhvostov AS
Klin Med (Mosk); 1999; 77(11):4-9. PubMed ID: 10635622
[No Abstract] [Full Text] [Related]
9. New molecular diagnostic methods in head and neck cancer.
Rodrigo JP; Ferlito A; Suárez C; Shaha AR; Silver CE; Devaney KO; Bradley PJ; Bocker JM; McLaren KM; Grénman R; Rinaldo A
Head Neck; 2005 Nov; 27(11):995-1003. PubMed ID: 16200629
[TBL] [Abstract][Full Text] [Related]
10. Cancer genomics: the chips are on the table.
Holland K; Sullivan M
N Z Med J; 2002 Oct; 115(1163):U204. PubMed ID: 12552310
[No Abstract] [Full Text] [Related]
11. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
Ross JS
Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622
[No Abstract] [Full Text] [Related]
12. Discussion of the applicability of microarrays: profiling of leukemias.
Haferlach T; Bacher U; Kohlmann A; Haferlach C
Methods Mol Biol; 2009; 509():15-33. PubMed ID: 19212712
[TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
Marshall FF
J Urol; 2005 Jun; 173(6):1918. PubMed ID: 15879775
[No Abstract] [Full Text] [Related]
14. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
[TBL] [Abstract][Full Text] [Related]
15. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
Merlio JP
Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
[No Abstract] [Full Text] [Related]
16. Proteomic approaches in cancer risk and response assessment.
Petricoin EF; Liotta LA
Trends Mol Med; 2004 Feb; 10(2):59-64. PubMed ID: 15102358
[TBL] [Abstract][Full Text] [Related]
17. Exploring the human genome in cancer with genomic approaches.
Scheel JR; Kuo MD
J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971
[No Abstract] [Full Text] [Related]
18. Discovering causes and cures for cancer from gene expression analysis.
Weeraratna AT
Ageing Res Rev; 2005 Nov; 4(4):548-63. PubMed ID: 16243590
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives.
Nannini M; Pantaleo MA; Maleddu A; Astolfi A; Formica S; Biasco G
Cancer Treat Rev; 2009 May; 35(3):201-9. PubMed ID: 19081199
[TBL] [Abstract][Full Text] [Related]
20. Individualized cancer therapy: molecular approaches to the prediction of tumor response.
McLeod HL
Expert Rev Anticancer Ther; 2002 Feb; 2(1):113-9. PubMed ID: 12113060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
